Sarcoidosis News and Research

RSS
Sarcoidosis is a disease of unknown cause that leads to inflammation. It can affect various organs in the body. Normally, your immune system defends your body against foreign or harmful substances. For example, it sends special cells to protect organs that are in danger. These cells release chemicals that recruit other cells to isolate and destroy the harmful substance. Inflammation occurs during this process. Once the harmful substance is destroyed, the cells and the inflammation go away. In people who have sarcoidosis, the inflammation doesn't go away. Instead, some of the immune system cells cluster to form lumps called granulomas in various organs in your body.
New findings offer insights into novel treatment avenue for Crohn's Disease, sarcoidosis

New findings offer insights into novel treatment avenue for Crohn's Disease, sarcoidosis

Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval

Questcor's H.P. Acthar Gel sNDA for infantile spasms receives FDA approval

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck's boceprevir Phase III studies for HCV to be presented at 61st AASLD

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Merck signs non-exclusive license agreement with LabCorp for commercialization of genetic test

Twelve residents receive one-year fellowship grant to study medical dermatology

Twelve residents receive one-year fellowship grant to study medical dermatology

Excess levels of a protein associated with TNF may produce cognitive decline: Studies

Excess levels of a protein associated with TNF may produce cognitive decline: Studies

Johns Hopkins researchers identify a key protein that triggers sarcoidosis

Johns Hopkins researchers identify a key protein that triggers sarcoidosis

PhRMA President honors Ron and Raychel Bartek for driving awareness of Friedreich's ataxia

PhRMA President honors Ron and Raychel Bartek for driving awareness of Friedreich's ataxia

Quercetin may prevent hepatitis C infection; findings may lead to less toxic treatments

Quercetin may prevent hepatitis C infection; findings may lead to less toxic treatments

Interim data from Schering-Plough's narlaprevir Phase IIa study

Interim data from Schering-Plough's narlaprevir Phase IIa study

Schering-Plough receives FDA complete response letter regarding PEGINTRON

Schering-Plough receives FDA complete response letter regarding PEGINTRON

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Schering-Plough receives FDA recommendation approval for PEGINTRON

Schering-Plough receives FDA recommendation approval for PEGINTRON

National Cancer Institute grants $9.1M award to BUSM

National Cancer Institute grants $9.1M award to BUSM

Chronic pediatric cough linked to reflux and allergies

Chronic pediatric cough linked to reflux and allergies

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

InterMune receives $20 million event payment from Roche for initiating the Phase 2b trial of RG7227/ ITMN-191

Autoantibodies may be created in response to bacterial DNA

Autoantibodies may be created in response to bacterial DNA

May hepatic granulomas be part of the histological spectrum of chronic hepatitis C?

May hepatic granulomas be part of the histological spectrum of chronic hepatitis C?

Biomarkers identified for idiopathic pulmonary fibrosis

Biomarkers identified for idiopathic pulmonary fibrosis